Based in Southern California, Dr. Arthur Mikaelian has a commitment to developing new medical technologies that improve people’s lives through tissue rejuvenation and the treatment of tumors. An independent researcher, he has applied quantum physics and quantum biology principles in devising a polarization technology. Dr. Arthur Mikaelian’s approach boosts active compound potency across various material types. He has worked with an international bio-pharmaceutical company in testing polarized scorpion peptides for oncology patients.
Dr. Mikaelian completed his PhD in biological-neuropsychology at the Vernadsky Foundation University in the late 1980s. He researched cortisol, epinephrine, and other stress hormones, as well as master genes’ indirect influence on tumor progression. Building on this work, he guided a Los Angeles clinic/institute in the late 1990s that improved the way psychosomatic illnesses were diagnosed and treated. Dr. Mikaelian’s collaborative approach advanced the scientific status quo and created new targeted interventions for those with complex conditions.
Dr. Arthur Mikaelian’s innovations extend to a universal system of modeling medical conditions. This pioneering medical AI program provides ways of improving the efficacy of delivering groundbreaking medications and therapies, and generating real world results.